Kevin Perraud
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
Papers in
- Oncology 3
-
- Prostate Cancer Treatment and Research 1
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Annette Jappe (2 shared papers)Armando Santoro (2 shared papers)Stéphane Cattan (2 shared papers)Junji Furuse (2 shared papers)Andrew X. Zhu (2 shared papers)Masatoshi Kudo (2 shared papers)Bruno Daniele (2 shared papers)Arndt Vogel (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)JAMA (1 paper)Clinical Lymphoma Myeloma & Leukemia (1 paper)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Kevin Perraud
6 papers receiving 514 citations
Kevin Perraud's Hit Papers
Peers
Comparison fields: 5 of 41
- Hepatology 314
- Pathology and Forensic Medicine 133
- Cancer Research 82
- Oncology 101
- Epidemiology 115
Countries citing papers authored by Kevin Perraud
This map shows the geographic impact of Kevin Perraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Perraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Perraud more than expected).
Fields of papers citing papers by Kevin Perraud
This network shows the impact of papers produced by Kevin Perraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Perraud. The network helps show where Kevin Perraud may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Perraud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib Hit paper breakdown → | 2014 | 450 |
| 2 | 2014 | 33 | |
| 3 | 2009 | 26 | |
| 4 | 2025 | 8 | |
| 5 | 2022 | 1 | |
| 6 | 2018 | 1 |
About Kevin Perraud
Kevin Perraud is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Organic Chemistry and Epidemiology, having authored 6 papers that have together received 519 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Prostate Cancer Treatment and Research (1 paper), Lung Cancer Treatments and Mutations (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Quinazolinone synthesis and applications (1 paper) and Eosinophilic Disorders and Syndromes (1 paper). The work is most often cited by research in Hepatology (314 citations), Pathology and Forensic Medicine (133 citations), Cancer Research (82 citations), Oncology (101 citations) and Epidemiology (115 citations). Kevin Perraud has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Annette Jappe, Armando Santoro, Stéphane Cattan, Junji Furuse, Andrew X. Zhu, Masatoshi Kudo, Bruno Daniele, Arndt Vogel, Yoon‐Koo Kang and Ho Yeong Lim. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Nuclear Medicine and Molecular Imaging, Cancer Chemotherapy and Pharmacology, JAMA and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.